 | SQI Diagnostics is a diagnostic systems company focused on developing and launching an automated, multiplex immunoassay platform serving the human healthcare market. The Company is initially focused on the autoimmune disease testing segment and is expected to advance its technology into other markets including infectious disease detection and allergen screening. The SQiDworks™ automated platform and the QuantiSpot™ consumable microarray have the potential to significantly reduce processing time, labor thereby reducing overall laboratory test costs by up to 40%.
|